More than 2.6 million people in the United States are affected by atrial fibrillation (AF), an irregular heart rhythm that can lead to clot-provoked stroke.
The National Blood Clot Alliance developed and designed a new online learning module to help educate healthcare professionals (HCPs) about anticoagulation options for stroke prevention in AF patients.
We’re pleased to make this new content for HCPs available on our website today. NBCA extends its appreciation to Boehringer Ingelheim for its support of this program.
Access the new learning module here: AF Learning Module.
